Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,345	1,435	1,736	1,801	1,959	2,121
Short-Term Investments	337.74	174.26	159.52	70.8	80.8	201.8
Cash & Short-Term Investments	1,683	1,609	1,896	1,872	2,040	2,323
Cash Growth	-1.17%	-15.10%	1.27%	-8.25%	-12.19%	26.68%
Accounts Receivable	851.31	847.2	783.01	730.48	580.03	524.06
Other Receivables	15.27	21.44	26.94	27.66	33.53	18.17
Receivables	866.58	868.64	809.94	758.15	613.55	542.23
Inventory	935.32	1,065	1,147	1,304	1,082	1,350
Prepaid Expenses	125.85	137.26	118.23	162.21	136.07	87.96
Other Current Assets	33.59	295.84	257.28	88.62	53.63	13.89
Total Current Assets	3,644	3,976	4,228	4,185	3,925	4,317
Property, Plant & Equipment	3,832	3,851	3,986	4,019	4,181	2,894
Long-Term Investments	2,929	2,296	1,064	533.57	416.83	191.06
Other Intangible Assets	43.75	43.76	42.69	43.01	78.16	104.48
Long-Term Deferred Tax Assets	610.71	623.1	677.16	588.05	631.87	522.46
Other Long-Term Assets	761.68	780.13	814.28	1,062	170.82	130.57
Total Assets	11,822	11,570	10,812	10,430	9,403	8,160
Accounts Payable	240.82	176.13	348.07	552.2	159.81	318.76
Accrued Expenses	-	296.94	274.85	353.04	390.66	456.17
Short-Term Debt	2,110	2,112	2,324	2,191	2,050	1,225
Current Portion of Long-Term Debt	-	379.89	272.31	350.18	246.82	158.57
Current Portion of Leases	34.54	38.79	41.95	44.06	25.78	32.41
Current Income Taxes Payable	30.06	20.21	138.39	16.02	55.52	13.76
Other Current Liabilities	866.26	283.6	312.65	286.42	303.12	224.54
Total Current Liabilities	3,282	3,308	3,712	3,793	3,232	2,429
Long-Term Debt	1,265	1,343	1,790	1,991	1,680	758.28
Long-Term Leases	333.08	354.37	412.89	447.92	218.46	229.47
Long-Term Deferred Tax Liabilities	683.7	670.13	651.99	671.26	728.29	746.01
Other Long-Term Liabilities	68.87	22.9	23.44	23.3	24.65	26.83
Total Liabilities	5,632	5,746	6,649	6,987	5,950	4,255
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	271.26	271.26	271.26	271.26	263.44	260.77
Retained Earnings	2,171	2,046	1,752	1,738	2,118	2,274
Comprehensive Income & Other	2,198	1,979	624.12	51.9	-307.04	-193.43
Total Common Equity	5,507	5,164	3,514	2,929	2,942	3,209
Minority Interest	682.85	660.39	648	514.77	511.39	696.34
Shareholders' Equity	6,190	5,824	4,162	3,444	3,453	3,905
Total Liabilities & Equity	11,822	11,570	10,812	10,430	9,403	8,160
Total Debt	3,743	4,229	4,841	5,024	4,221	2,403
Net Cash (Debt)	-2,059	-2,620	-2,946	-3,153	-2,181	-80.19
Net Cash Per Share	-23.71	-30.20	-33.88	-36.34	-25.08	-0.92
Filing Date Shares Outstanding	86.85	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.85	86.75	86.75	86.75	86.75	86.75
Working Capital	362.46	667.71	515.42	391.79	693.29	1,888
Book Value Per Share	63.41	59.53	40.51	33.76	33.91	36.99
Tangible Book Value	5,463	5,120	3,472	2,886	2,864	3,104
Tangible Book Value Per Share	62.90	59.03	40.02	33.27	33.01	35.78
Land	-	1,157	1,169	1,169	1,462	578.12
Buildings	-	2,300	2,347	2,243	2,190	1,754
Machinery	-	1,083	1,069	992.9	965.5	918.07
Construction In Progress	-	27.78	3.55	36.12	48.41	0.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.